Elecoglipron moves to Phase III: what the new oral GLP-1 trial means
AstraZeneca has moved elecoglipron into Phase III, adding a new future-tablet headline to the oral GLP-1 conversation.
18 June 2026 · 2 min readNews and updates
Shorter, timely site updates and comparison-coverage notes that help readers understand what is new and what can now be checked more clearly.
Most people who stop GLP-1 treatment eventually restart
New ENDO 2026 data shows many GLP-1 users stop and later restart, which makes switching, maintenance and repeat-review wording more important.
18 June 2026 · 2 min read
GLP-1 users are losing weight but moving less
New ENDO 2026 data suggests GLP-1 users may be losing weight while moving less, which makes routine and support questions more important on provider pages.
18 June 2026 · 2 min read
This week’s comparison update: where the parent site now gives a clearer shortlist
A short update on where the parent comparison now gives a clearer shortlist before readers move deeper.
17 June 2026 · 2 min read
Wegovy pill approved in the UK: what changes for weight-loss comparison now?
The Wegovy pill was approved by the MHRA on 11 June 2026. For WeightLossComparison readers, the useful change is not just that a new medicine headline exists. It…
13 June 2026 · 3 min read
This week’s comparison update: newer last-checked dates and what they change
A short update on newer checked dates and why freshness changes how confidently a comparison row can be used.
10 June 2026 · 2 min read
Do GLP-1 drugs reduce cancer risk? What the June 2026 evidence actually shows
New cancer-related GLP-1 headlines are interesting, but they need careful reading. Here is what the June 2026 evidence suggests and what it does not prove.
3 June 2026 · 3 min read New semaglutide kidney data: what the June 2026 FLOW analysis means
Fresh June 2026 reporting on semaglutide and kidney outcomes is important, but it applies to a more specific clinical setting than many headlines suggest.
3 June 2026 · 3 min read France to reimburse Wegovy and Mounjaro: what UK comparison readers should know
France will start reimbursing Wegovy and Mounjaro from June 15, 2026 under specific rules. Here is what that means, and what UK readers should not assume from the…
3 June 2026 · 3 min read This week’s comparison update: what changed in our provider and tablet checks
A short update on new provider checks, tablet options, and where the parent comparison has become more useful.
3 June 2026 · 2 min read